Ethnic differences in osteocalcin γ-carboxylation, plasma phylloquinone (vitamin K1) and apolipoprotein E genotype

European Journal of Clinical Nutrition

Volumn 59, Issue 1, 2005, Pages 72-81

  Beavan, S R ^a,e   Prentice, Ann ^a   Stirling, D M ^a   Dibba, B ^b   Yan, L ^a,c   Harrington, D J ^d   Shearer, M J ^d  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b MRC ^*  (Gambia)

^c SHENYANG MEDICAL COLLEGE   (China)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e Pharmagene Laboratories Ltd   (United Kingdom)

Author keywords

carboxylation; apoE genotype; Ethnic; Osteocalcin; Osteoporosis; Vitamin K

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; OSTEOCALCIN; PHYTOMENADIONE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CARBOXYLATION; CHINESE; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; FRACTURE; GAMBIA; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; POSTMENOPAUSE OSTEOPOROSIS; PREMENOPAUSE; PREVALENCE; RISK ASSESSMENT; UNITED KINGDOM;

ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; APOLIPOPROTEINS E; CHINA; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; GAMBIA; GENOTYPE; HUMANS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS; VITAMIN K 1;

EID: 12144268311     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602037     Document Type: Article

References (48)

1. Adebajo AO, Cooper C & Evans JG (1991): Fractures of the hip and distal forearm in West Africa and the United Kingdom. Age Ageing 20, 435-438.
2. Aspray TJ, Prentice A, Cole TJ, Sawo Y, Reeve J & Francis RM (1996): Low bone mineral content is common but osteoporotic fractures are rare in elderly rural Gambian women. J. Bone Miner. Res. 11, 1019-1025.
3. Binkley NC & Suttie JW (1995): Vitamin K nutrition and osteoporosis. J. Nutr. 125, 1812-1821.
4. Bitensky L, Hart JP, Catterall A, Pilkington MJ & Chayen J (1988): Circulating vitamin K levels in patients with fractures. J. Bone Joint Surg. 70-B, 663-664.
5. Booth SL, Sokoll LJ, O'Brien ME, Tucker K, Dawson-Hughes B & Sadowski JA (1995): Assessment of dietary phylloquinone intake and vitamin K status in postmenopausal osteoporosis. Eur. J. Clin. Nutr. 49, 832-841.
6. Booth S, Pennington J & Sadowski J (1996): Food sources and dietary intakes of vitamin K1 (phylloquinone) in the American diet: data from the FDA Total Diet Survey. J. Am. Diet Assoc. 96, 149-154.
7. Booth SL, Tucker KL, McKeown NM, Davidson KW, Dallal GE & Sadowski JA (1997): Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J. Nutr. 127, 587-592.
8. Booth SL, O'Brein-Morse ME, Dallal GE, Davidson KW & Gundberg CM (1999): Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: comparison of younger and older adults. Am. J. Clin. Nutr. 70, 368-377.
9. Booth SL, Tucker KL, Chen HL, Hannan MT, Gagnon DR, Cupples LA, Wilson PWF, Ordovas J, Schaefer EJ, Dawson-Hughes B & Kiel DP (2000): Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am. J. Clin. Nutr. 71, 1201-1208.
10. Cauley JA, Zmuda JM, Yaffe K, Kuller LH, Ferrell RE, Wisniewski SR & Cummings SR (1999): Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk - the study of osteoporotic fractures. J. Bone Miner. Res. 14, 1175-1181.
11. Cullen P, Cignarella A, Brennhausen B, Mohr S, Assmann G & von Eckardstein A (1998): Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J. Clin. Invest. 101, 1670-1677.
12. Cummings SR, Cauley JA, Palmero L, Ross PD, Wasnich RD, Black D & Faulkner KG (1994): Racial differences in hip axis lengths might explain differences in rates of hip fracture. Osteoporosis Int. 4, 226-229.
13. Davidson KW & Sadowski JA (1997): Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorometric detection. Methods Enzymol. 282, 408-421.
14. Davignon J, Gregg RE & Sing CF (1988): Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 18, 1-21.
15. Dowd P, Ham S-W, Naganathan S & Hershline R (1995): The mechanism of action of vitamin K. Ann. Rev. Nutr. 15, 419-440.
16. Ferland G, Sadowski JA & O'Brein ME (1993): Dietary induced vitamin K deficiency in normal human subjects. J. Clin. Invest. 91, 1761-1768.
17. Gundberg CM, Nieman SD, Abrams S & Rosen H (1998): Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J. Clin. Endocrinol. Metab. 83 3258-3266.
18. Hart JP, Shearer MJ, Klenerman L, Catterall A, Reeve J, Sambrook PN, Dodds RA, Bitensky L & Chayen J (1985): Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J. Clin. Endocrinol. Metab. 60, 1268-1269.
19. Heikkinen AM, Kroger H, Niskanen L, Komulainen MH, Ryynanen M, Parviainen MT, Tuppurainen MT, Honkanen R & Saarikoski S (2000): Does apoliopoprotein E genotype relate to BMD and bone markers in postmenopausal women? Maturitas 34, 33-41. 2000.
20. Knapen MHJ, Hamulyak K & Vermeer C (1989): The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann. Intern. Med. 111, 1001-1005.
21. Knapen MHJ, Jie K-S, G, Hamalyak K & Vermeer C (1993): Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss. Calcif. Tissue Int. 53, 81-85.
22. Kohlmeier M, Saupe J, Shearer MJ, Schaefer K & Asmus G (1997): Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int. 51, 1218-1221.
23. Kohlmeier M, Saupe J, Schaefer K & Asmus G (1998): Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif. Tissue Int. 62, 278-281.
24. Lamon-Fava S, Sadowski JA, Davidson KW, O'Brein ME, McNamara JR & Schaefer EJ (1998): Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am. J. Clin. Nutr. 67, 1226-1231.
25. Lau EMC & Cooper C (1996): The epidemiology of osteoporosis: the Oriental perspective in a world context. Clin. Orthop. 323 65-74.
26. Mahley RW & Hussain MM (1991): Chylomicron and chylomicron remnant catabolism. Curr. Opin. Lipidol. 2, 170-176.
27. McCarthy PT, Harrington DJ & Shearer MJ (1997): Assay of phylloquinone in plasma by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 282, 421-433.
28. Merle D & Delmas PD (1990): Normal carboxylation of circulating osteocalcin in Paget's disease of the bone. Bone Miner. 11, 237-245.
29. Newman P, Bonello F, Wierzbicki AS, Lumb P, Savidge GF & Shearer MJ (2002): The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cell: role of heparan sulfate proteoglycans and apolipoprotein E. J. Bone Miner. Res. 17, 426-433.
30. Plantalech L & Guillamont M (1991): Impairment of gamma carboxylation of circulating osteocalcin (bone Gla protein) in elderly women. J. Bone Miner. Res. 6, 1211-1216.
31. Prentice A, Shaw J, Laskey MA, Cole TJ & Fraser DR (1991): Bone mineral content of British and rural Gambian women aged 18-80 + years. Bone Miner. 12, 201-214.
32. Prentice A, Parsons TJ & Cole TJ (1994): Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am. J. Clin. Nutr. 60, 837-842.
33. Prentice A, Yan L, Beavan S, Dibba B, Aspray T, Stirling D, Laskey MA & Ginty F (2001): Differences in markers of calcium metabolism and bone turnover in young and old British, Chinese and Gambian women. Ann. Nutr. Metab. 45, 247.
34. Price PA, Williamson MK & Lothringer JW (1981): Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J. Biol. Chem. 256, 12760-12766.
35. Roberts NB, Holding JD, Walsh HPJ, Klenerman L, Helliwell T, King D & Shearer M (1996): Serial changes in serum vitamin K, triglyceride, cholesterol, osteocalcin and 25-hydroxyvitamin D in patients after hip replacement for fractured neck of femur or osteoarthritis. Eur. J. Clin. Invest. 26, 24-29.
36. Sadowski JA, Hood SJ, Dallal GE & Garry PJ (1989): Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. Am. J. Clin. Nutr. 50, 100-108.
37. Saupe J, Shearer MJ & Kohlmeier M (1993): Phylloquinone transport and its influence on gamma-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis. Am. J. Clin. Nutr. 58, 204-208.
38. Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M & Ouchi Y (1997): Association of bone mineral density with apolipoprotein E phenotype. J. Bone Miner. Res. 12, 1438-1445.
39. Shiraki M, Shiraki Y, Aoki C & Miura M (2000): Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J. Bone Miner. Res. 15, 515-521.
40. Sokoll LJ & Sadowski JA (1996): Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am. J. Clin. Nutr. 63, 566-573.
41. Sokoll LJ, Booth SL, O'Brein ME, Davidson KW, Tsaioun KI & Sadowski JA (1997): Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am. J. Clin. Nutr. 65 779-784.
42. Solomon L (1968): Osteoporosis and fracture of the femoral neck in the South African Bantu. J Bone Joint Surg. 50B, 2-13.
43. Suttie JW, Mummah-Schendel LL, Shah DV, Lyle BJ & Greger JL (1988): Vitamin K deficiency from dietary vitamin K restriction in humans. Am. J. Clin. Nutr. 47, 475-480.
44. Szulc P, Chapuy M-C, Meunier PJ & Delmas PD (1993): Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest. 91, 1769-1774.
45. Wenham PR, Price WH & Blundell G (1991): Apolipoprotein E genotyping by one-stage PCR. Lancet 337, 1158-1159.
46. Vergnaud P, Garnero P, Meunier PJ, Breart G & Delmas PD (1997): Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women. J. Clin. Endocrinol. Metab. 82, 719-724.
47. Yan L, Zhou B, Prentice A, Wang X & Golden MH (1999): Epidemiological study of hip fracture in Shenyang, People's Republic of China. Bone 24, 151-155.
48. 1 intake in older people from Cambridge, UK and Shenyang, PR China. Proc. Nutr. Soc. 61, 149A.